Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
SAB Biotherapeutics (SABS) just unveiled an update.
The Company has announced the appointment of Mr. Conley through a press release on May 30, 2024. This information, while provided to the public, is not intended for legal liability under the Securities Exchange Act of 1934, nor is it to be included in any future securities filings unless explicitly stated.
For a thorough assessment of SABS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue